| Teresa George Abraham, PHARMD | |
|
2003 Medical Pkwy Ste G10, Annapolis, MD 21401-3065 | |
| (443) 481-5826 | |
| Not Available |
| Full Name | Teresa George Abraham |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 2003 Medical Pkwy Ste G10, Annapolis, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225412794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 059691 (New York) | Secondary |
| 1835P2201X | Pharmacist - Ambulatory Care | 27138 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Teresa George Abraham, PHARMD 2003 Medical Pkwy Ste G10, Annapolis, MD 21401-3065 Ph: (443) 481-5826 | Teresa George Abraham, PHARMD 2003 Medical Pkwy Ste G10, Annapolis, MD 21401-3065 Ph: (443) 481-5826 |
News Archive
Intimate partner violence (IPV) is a significant health issue faced by women veterans, but little has been known up until now about their preferences for IPV-related care. A new study has found that most of these women support routine screening for IPV and want options, follow-up support, transparent documentation and Veterans Health Administration and community resources.
Salix Pharmaceuticals, Ltd. today announced the U.S. Food and Drug Administration has granted marketing approval for XIFAXAN 550 mg tablets for reduction in risk of overt hepatic encephalopathy recurrence in patients 18 years of age or older. HE is a serious disorder caused by chronic liver failure, resulting in cognitive, psychiatric and motor impairments. This approval was supported by findings from the largest randomized trial of maintenance therapy in HE conducted to date, which assessed the efficacy and safety of XIFAXAN 550 mg tablets and demonstrated a statistically significant and clinically meaningful reduction in the risk of overt HE recurrence.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced that Stuart A. Randle, chief executive officer, will participate in a panel discussion as part of the 2010 Medical Innovation Summit being held at the Cleveland Clinic November 1-3, 2010 in Cleveland, Ohio.
A new review of studies on levels of urban exposure to airborne pollutants and their effects on human health suggests that advanced instrumentation and information technology will soon allow researchers and policymakers to gauge the health risks of air pollution on an individual level.
› Verified 9 days ago
Dr. Lawrence J Krebs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2002 Medical Pkwy, Ste 170, Annapolis, MD 21401 Phone: 410-573-6900 Fax: 410-573-1127 | |
Christie Dunton, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy Ste G10, Annapolis, MD 21401 Phone: 443-481-5826 | |
Binal Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 123 Main St, Annapolis, MD 21401 Phone: 410-295-3061 | |
Riyo Rajan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2001 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4157 | |
Jazzmine C Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2601 Riva Rd, Annapolis, MD 21401 Phone: 410-571-2090 Fax: 410-571-2896 | |
Margaret M Thomas, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Medical Pkwy, Annapolis, MD 21401 Phone: 443-481-4229 Fax: 443-481-4842 | |
Matthew Howard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 975 Bay Ridge Rd, Annapolis, MD 21403 Phone: 443-268-7688 Fax: 410-268-4597 |